Related references
Note: Only part of the references are listed.ECMO in COVID-19 Patients: A Systematic Review and Meta-analysis
Pietro Bertini et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2022)
Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients
Marina Camera et al.
FRONTIERS IN PHARMACOLOGY (2022)
Mild COVID-19 imprints a long-term inflammatory eicosanoid-and chemokine memory in monocyte-derived macrophages
Sina Bohnacker et al.
MUCOSAL IMMUNOLOGY (2022)
Urinary Cysteinyl Leukotrienes as Biomarkers of Endothelial Activation, Inflammation and Oxidative Stress and Their Relationship with Organ Dysfunction in Human Septic Shock
Marta Reina-Couto et al.
BIOMEDICINES (2022)
Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations
Peter L. Elkin et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19)
Yue Zhou et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)
Montelukast's ability to fight COVID-19 infection
Andrzej Bozek et al.
JOURNAL OF ASTHMA (2021)
Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
Benjamin Schwarz et al.
JOURNAL OF IMMUNOLOGY (2021)
Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization
Jenelle Badulak et al.
ASAIO JOURNAL (2021)
The immunomodulatory effects of macrolide antibiotics in respiratory disease
Jennifer Pollock et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2021)
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
Chris R. Triggle et al.
FRONTIERS IN IMMUNOLOGY (2021)
High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients
Anne-Sophie Archambault et al.
FASEB JOURNAL (2021)
Role of Hypertension on the Severity of COVID-19: A Review
Mei Peng et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2021)
Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
Francesco Palmas et al.
PLOS ONE (2021)
Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19
Dong-Min Kim et al.
CELL REPORTS (2021)
Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19
Mangaldeep Dey et al.
PHARMACOLOGY (2021)
Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients
Raphael Giraud et al.
PHYSIOLOGICAL REPORTS (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers
Kiran Shekar et al.
ASAIO JOURNAL (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Cardiovascular comorbidity and its impact on patients with COVID-19
Wei-jie Guan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Arterial hypertension and the risk of severity and mortality of COVID-19
Carlos Enrique Leiva Sisnieguez et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis
Wenjie Tian et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
Liver injury in COVID-19: The current evidence
Saleh A. Alqahtani et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19
Anand V. Kulkarni et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Biomarkers associated with COVID-19 disease progression
Giovanni Ponti et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)
A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
Colin D. Funk et al.
FRONTIERS IN PHARMACOLOGY (2020)
Clinical and pathological investigation of patients with severe COVID-19
Shaohua Li et al.
JCI INSIGHT (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships
Barry M. Popkin et al.
OBESITY REVIEWS (2020)
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
Ludwig Aigner et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome
A. Combes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cysteinyl Leukotrienes in Eosinophil Biology: Functional Roles and Therapeutic Perspectives in Eosinophilic Disorders
Glaucia A. Thompson-Souza et al.
FRONTIERS IN MEDICINE (2017)
Leukotrienes as a molecular link between obstructive sleep apnoea and atherosclerosis
Francoise Stanke-Labesque et al.
CARDIOVASCULAR RESEARCH (2014)
Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
A. J. Theron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Antileukotriene Agents for the Treatment of Lung Disease
Jacob P. Scott et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Adipocytes Secrete Leukotrienes: Contribution to Obesity-Associated Inflammation and Insulin Resistance in Mice
Isabelle Mothe-Satney et al.
DIABETES (2012)
Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea
Francoise Stanke-Labesque et al.
JOURNAL OF LIPID RESEARCH (2012)
Leukotriene B4 Receptor-1 Mediates Intermittent Hypoxia-induced Atherogenesis
Richard C. Li et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Cysteinyl Leukotrienes Impair Hypoxic Pulmonary Vasoconstriction in Endotoxemic Mice
Bodil Petersen et al.
ANESTHESIOLOGY (2011)
Leukotrienes and airway inflammation
Katsuhide Okunishi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2011)
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease
Daniel Poeckel et al.
CARDIOVASCULAR RESEARCH (2010)
A catalogue of reporting guidelines for health research
I. Simera et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Hypoxia-Mediated Expression of 5-Lipoxygenase-Activating Protein Involves HIF-1α and NF-κB and MicroRNAs 135a and 199a-5p
Caryn S. Gonsalves et al.
JOURNAL OF IMMUNOLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial
Giles J. Peek et al.
LANCET (2009)
Montelukast inhibits tumour necrosis factor-α-mediated interleukin-8 expression through inhibition of nuclear factor-κB p65-associated histone acetyltransferase activity
F. Tahan et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Expanding roles for leukotrienes in airway inflammation
Marc Peters-Golden
CURRENT ALLERGY AND ASTHMA REPORTS (2008)
Corticosteroids as inhibitors of cysteinyl leukotriene metabolic and signaling pathways
Julie Negri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Mechanisms of disease: Leukotrienes
Marc Peters-Golden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Lipoteichoic acids selectively stimulate rat mast cells to cysteinyl leukotriene generation and affect mast cell migration after tumor necrosis factor (TNF)-priming
Ewa Brzezinska-Blaszczyk et al.
IMMUNOLOGY LETTERS (2007)
Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis
M. Peters-Golden et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Leukotriene modifiers as potential therapeutics for cardiovascular disease
CD Funk
NATURE REVIEWS DRUG DISCOVERY (2005)
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels
S Gangemi et al.
EXPERIMENTAL GERONTOLOGY (2005)
Cysteinyl leukotrienes and their receptors: (Cellular distribution and function in immune and inflammatory responses
Y Kanaoka et al.
JOURNAL OF IMMUNOLOGY (2004)
Eosinophils and cysteinyl leukotrienes
C Bandeira-Melo et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
High levels of urinary leukotriene E-4 excretion in steroid treated patients with severe asthma
I Vachier et al.
RESPIRATORY MEDICINE (2003)
Involvement of cysteinyl leukotrienes in angiotensin II-induced contraction in isolated aortas from transgenic (mRen-2)27 rats
F Stanke-Labesque et al.
JOURNAL OF HYPERTENSION (2002)
Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR
S Shastri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats
F Stanke-Labesque et al.
CARDIOVASCULAR RESEARCH (2001)
Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition
F Stanke-Labesque et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
